HIV Assays

Accelevir’s HIV-1 Persistence Assays are crafted to meet the evolving demands of HIV cure research. Our suite of advanced assays offers precise tools to quantify and analyze HIV-1 reservoirs, addressing one of the greatest challenges in HIV research—understanding and targeting persistent viral reservoirs that evade immune responses and antiretroviral therapy.

Our Intact Proviral DNA Assay (IPDA) stands out for its unparalleled accuracy in measuring intact HIV-1 genomes. With a focus on integrity and reliability, the IPDA provides researchers with the clarity needed to detect viable HIV-1 proviruses, offering deeper insights into latent reservoirs. Paired with our RNA-based assays, Accelevir enables a multidimensional look at viral persistence, helping to illuminate the pathways that sustain HIV despite treatment.

Driven by rigorous standards and a commitment to advancing HIV research, Accelevir’s team collaborates closely with our clients to customize assay solutions, ensuring data is as actionable as it is insightful. Our expertise is backed by a deep understanding of the clinical complexities surrounding HIV persistence, and we prioritize each study’s unique requirements to provide assays that align with groundbreaking research efforts. 

By working with Accelevir, you gain access to more than assays; you join a partnership dedicated to pushing the boundaries of what’s possible in HIV research. Together, we’re helping to unlock the science that could one day lead to a cure.